跳至主要内容
临床试验/NCT07561814
NCT07561814招募中不适用

A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 1,030 人开始时间: 2025年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,030
试验地点
1
主要终点
overall survival

研究概览

简要总结

The goal of this observational study is to learn if combining information from CT scans, blood tests, and pathology reports can better predict how pancreatic cancer will progress.

The main questions it aims to answer are:

  • Can combining these types of data more accurately estimate how long a person might survive?
  • Can it better predict the risk of recurrence?

Participants will not have any extra tests or treatments. They will:

  • Allow researchers to collect information from their existing medical records (such as surgery reports, imaging, and lab results)
  • Receive a follow-up phone call for up to 3 years to share health updates(about every 3 months for the prospective cohort).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Histologically or cytologically confirmed diagnosis of pancreatic cancer.
  • Availability of preoperative and postoperative contrast-enhanced CT images at the participating center; patient records include corresponding clinical data, postoperative pathological reports, and preoperative and postoperative blood test results.
  • Underwent surgical treatment for pancreatic cancer at a participating center of this study.

排除标准

  • Age < 18 years (minors).
  • Presence of other severe diseases (e.g., severe liver or kidney failure, cardiovascular or cerebrovascular diseases, malignancies other than pancreatic cancer); pregnant or breastfeeding women; individuals with mental illness;
  • patients unable to comply with follow-up or provide informed consent.
  • Presence of significant outliers (e.g., laboratory values exceeding 10 times the normal range without clinically reasonable explanation) or samples with excessive missing data.

研究组 & 干预措施

prospective cohort

Retrospective cohort

结局指标

主要结局

overall survival

时间窗: 3 years

recurrence free survival

时间窗: 3 years

recurrence status within one year after surgery

时间窗: 3 years

次要结局

未报告次要终点

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验